Cargando…

Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target

The vascular obstructive thrombus is composed of a mesh of fibrin fibers with blood cells trapped in these networks. Enhanced fibrin clot formation and/or suppression of fibrinolysis are associated with an increased risk of vascular occlusive events. Inhibitors of coagulation factors and activators...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsayejh, Basmah, Kietsiriroje, Noppadol, Almutairi, Mansour, Simmons, Katie, Pechlivani, Nikoletta, Ponnambalam, Sreenivasan, Ajjan, Ramzi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674435/ https://www.ncbi.nlm.nih.gov/pubmed/36452200 http://dx.doi.org/10.1055/a-1957-6817

Ejemplares similares

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
por: Altalhi, Rawan, et al.
Publicado: (2021)

The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk
por: Safdar, Nawaz Z., et al.
Publicado: (2023)

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
por: Pearson, Sam, et al.
Publicado: (2019)

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
por: Pechlivani, Nikoletta, et al.
Publicado: (2021)

Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study
por: Nishtala, Revathi, et al.
Publicado: (2020)

Risk factors associated with mortality in individuals with type 2 diabetes following an episode of severe hypoglycaemia. Results from a randomised controlled trial
por: Pearson, Sam M, et al.
Publicado: (2022)

The relative contribution of diurnal and nocturnal glucose exposures to HbA1c in type 1 diabetes males: a pooled analysis
por: Campbell, Matthew D., et al.
Publicado: (2022)

Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study
por: Kietsiriroje, Noppadol, et al.
Publicado: (2022)

Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk
por: King, Rhodri J., et al.
Publicado: (2020)

Antithrombotic therapy in diabetes: which, when, and for how long?
por: Ajjan, Ramzi A, et al.
Publicado: (2021)

Dietary fat intake is associated with insulin resistance and an adverse vascular profile in patients with T1D: a pooled analysis
por: Kietsiriroje, Noppadol, et al.
Publicado: (2022)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin
Publicado: (1977)

STUDIES OF THE PLASMIN SYSTEM : III. PHYSICAL PROPERTIES OF THE TWO PLASMIN INHIBITORS IN PLASMA
por: Norman, Philip S., et al.
Publicado: (1958)

Elevation of Plasmin-α2-plasmin Inhibitor Complexes in Patients with AL Amyloidosis
por: Miyazaki, Kanji, et al.
Publicado: (2018)

Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets
por: Sagar, Rebecca C., et al.
Publicado: (2022)

Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study
por: Kietsiriroje, Noppadol, et al.
Publicado: (2015)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021)

Plasmin inhibitor deficiency: A case report
por: Aissaoui, Ouissal, et al.
Publicado: (2020)

QUANTITATIVE STUDIES ON THE TOTAL PLASMIN AND THE TRYPSIN INHIBITOR OF HUMAN BLOOD SERUM : I. METHODS FOR THE TITRATION OF TOTAL PLASMIN AND OF TRYPSIN INHIBITOR
por: Todd, Edgar W.
Publicado: (1949)

SAT-074 Using Ipsilateral and Contralateral Ratios from Adrenal Vein Samples to Identify Functioning Adrenal Adenoma in Patients with Primary Aldosteronism
por: Suntornlohanakul, Onnicha, et al.
Publicado: (2019)

STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA
por: Norman, Philip S.
Publicado: (1958)

Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema
por: Elsawy, Moataz F
Publicado: (2012)

Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease
por: Cuthbert, Gary A., et al.
Publicado: (2020)

Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein
por: Ishiguro, Kazuya, et al.
Publicado: (2017)

Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
por: Gauer, Julia S., et al.
Publicado: (2022)

Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease
por: Stephen, Sam L., et al.
Publicado: (2010)

Plasmin and Articular Cartilage
por: Chrisman, O. Donald, et al.
Publicado: (1962)

Effect of phytosterols and inulin-enriched soymilk on LDL-cholesterol in Thai subjects: a double-blinded randomized controlled trial
por: Kietsiriroje, Noppadol, et al.
Publicado: (2015)

Geographical inequality in service utilization for primary aldosteronism screening: spatial epidemiological study in Southern Thailand
por: Suntornlohanakul, Onnicha, et al.
Publicado: (2022)

The Spatial Epidemiology of Patients Who Were Screened for and Diagnosed With Primary Aldosteronism in Southern Thailand
por: Suntornlohanakul, Onnicha, et al.
Publicado: (2021)

Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors
por: Purwin, Maciej, et al.
Publicado: (2016)

Antifibrinolytic Role of a Bee Venom Serine Protease Inhibitor That Acts as a Plasmin Inhibitor
por: Choo, Young Moo, et al.
Publicado: (2012)

Plasmin Inhibitors Prevent Leukocyte Accumulation and Remodeling Events in the Postischemic Microvasculature
por: Reichel, Christoph A., et al.
Publicado: (2011)

Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure.
por: Meijer, Piet, et al.
Publicado: (2001)

ANGPTL4/8 promotes plasmin-mediated cleavage of LPL inhibitors
por: Kersten, Sander
Publicado: (2023)

Phytosterols and inulin-enriched soymilk increases glucagon-like peptide-1 secretion in healthy men: double-blind randomized controlled trial, subgroup study
por: Kietsiriroje, Noppadol, et al.
Publicado: (2018)

QUANTITATIVE STUDIES ON THE TOTAL PLASMIN AND THE TRYPSIN INHIBITOR OF HUMAN BLOOD SERUM : II. VARIATIONS IN THE BLOOD CONCENTRATION OF TOTAL PLASMIN AND OF TRYPSIN INHIBITOR IN STREPTOCOCCAL DISEASES WITH SPECIAL REFERENCE TO RHEUMATIC FEVER
por: Todd, Edgar W.
Publicado: (1949)

Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection
por: Otamas, Anastasia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ju5gucagmhaqm607b26g8ufrt